Interleukin‐2 receptor β and γ chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus‐1 gp120
- 1 September 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (9) , 2188-2194
- https://doi.org/10.1002/eji.1830270911
Abstract
We have observed that CD4 T lymphocytes from human immunodeficiency virus (HIV)‐infected patients marginally express interleukin‐2 receptor (IL‐2R)β and IL‐2Rγ chains which are essential for IL‐2 signal transduction. To analyze this observation further, we studied the influence of gp120 on the cell surface expression of IL‐2Rβ and IL‐2Rγ by purified CD4 lymphocytes in vitro. Cross‐linking of the T cell receptors of these lymphocytes initiates entry into the cell cycle as measured by CD69 and CD71 cell surface expression and [3H]thymidine incorporation. It also induces the cell surface expression of IL‐2Rβ and IL‐2Rγ. We have shown that treatment of the CD4 T lymphocytes with HIV‐1 gp120 before anti‐CD3 stimulation impedes cell cycle progression as measured by reduced CD71 expression and inhibition of [3H]thymidine incorporation. Furthermore, cell surface expression of IL‐2Rβ and IL‐2Rγ subunits, which form the functional intermediate‐affinity IL‐2R, are significantly inhibited. More importantly, addition of exogenous IL‐2 does not restore the proliferation of the CD4 T cells treated with gp120, suggesting that cells are anergic and/or that the remaining IL‐2R are not functional. This is the first study of IL‐2Rβ and IL‐2Rγ dysregulation in the context of HIV infection and shows that CD4 is also involved in IL‐2R expression.Keywords
This publication has 30 references indexed in Scilit:
- gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individualsAIDS, 1997
- Interleukin 2 and its receptors: recent advances and new immunological functionsImmunology Today, 1996
- CD4 mAbs PREVENT PROGRESSION OF ALLOACTIVATED CD4+ T CELLS INTO THE S PHASE OF THE CELL CYCLE WITHOUT INTERFERING WITH EARLY ACTIVATION SIGNALS1Transplantation, 1996
- Cell Surface Phenotypic Changes Induced in H9 T Cells Chronically Infected with HTLV Type I or HIV Type 1 or Coinfected with the Two VirusesAIDS Research and Human Retroviruses, 1995
- Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-χB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activityEuropean Journal of Immunology, 1994
- The Interleukin-2 Receptor Subunit Expression and Function on Peripheral Blood Lymphocytes from HIV-Infected and Control PersonsClinical Immunology and Immunopathology, 1994
- T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?Immunology Today, 1993
- Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual menClinical and Experimental Immunology, 1993
- Abnormal expression of IL-2Rβ (p70)-binding polypeptide on HIV-infected patients' cellsCellular Immunology, 1992
- CCA (disodium 4-chloro-2,2′-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHAClinical Immunology and Immunopathology, 1990